Clinical Expertise Autoimmune Diseases Cardio and Peripheral Vascular Diseases CNS Diseases Dermatology and Wound Care Diabetes, Obesity, and Endocrine Diseases Genitourinary Diseases Infectious Diseases Oncology and Hematology Ophthalmology and Otolaryngology Orthopedics Respiratory Conditions Women's Health Other Clinical Areas Functional Expertise Industry Expertise Focus Areas Autoimmune Diseases Autoimmune diseases are not a single therapeutic area, but rather a spectrum of indications with overlapping mechanisms. Rheumatoid arthritis, psoriasis, systemic lupus erythematosus, multiple sclerosis, Crohn’s disease, ulcerative colitis and other inflammatory diseases frequently share molecular targets, raising the question of which indication to pursue first. Development plans must account not only for mechanistic fit, but also market size and pricing strategy. The challenge is to adopt a planning process that leverages core skills and assets across therapeutic category boundaries in order to fully realize a candidate’s commercial potential. Indications in which Health Advances has expertise include: Crohn’s disease Inflammatory bowel disease Multiple sclerosis Neuromyelitis optica Psoriasis Rheumatoid arthritis Scleroderma Sjogren’s syndrome Systemic lupus erythematosus Type 1 diabetes Ulcerative colitis Vitiligo Selected Experience download our autoimmune diseases brochure. (PDF 650KB) learn more about our work in autoimmune diseases. see an example of a client case on clinical development strategy for inflammatory bowel disease.

Health Advances All Rights Reserved.     Privacy    Terms of Use